Holiday Notification: Cayman Chemical will be closed Monday, September 6, 2010, in observance of the Labor Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, September 7, 2010. Thank you for your patience.
Research Area · Cardiology
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12730 |
15(S)- |
85280-90-6 | >95% |
|
71.330405156538 | 15-s-15-methyl-prostaglandin-d2 | 15(S)-15-methyl PG2 | 15(S)-15-methyl-PGD2 prostaglandins vasoconstriction analogs 15S-15-methyl-PGD2 | |||
| 12750 |
16,16- |
64072-59-9 | >98% |
|
✓ | 90.034696132597 | 16-16-dimethyl-prostaglandin-d2 | 16,16-dimethyl PGD2 | 16,16-dimethyl-PGD2 prostaglandins | ||
| 13050 |
1a,1b- |
- | >98% |
|
33.954972375690 | 1a-1b-dihomo-prostaglandin-e1 | 1a,1b-dihomo PGE1 | 1a,1b-dihomo-PGE1 prostaglandins | |||
| 9000462 |
2,3- |
- | ≥99% deuterated product |
|
2010-05-07 | 40.331491712707 | 2-3-dinor-6-keto-prostaglandin-f1-d9-sodium-salt | 2,3-dinor-6-keto PGF1α-d9 (sodium salt) | PGI2 metabolites 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-6-keto-PGF1.alpha. prostaglandins PGs MS LC-MS LC/MS GC-MS GC/MS mass spectrometry deuterium deuterated | ||
| 515121 |
2,3- |
- |
|
2006-05-23 | 162.024033149171 | 2-3-dinor-6-keto-prostaglandin-f1-eia-kit | 2,3-dinor-6-keto PGF1α ELISA Kit | enzymes immunoassays Prostaglandins PGI2 prostacyclin vascular myocardial infarction inhibits cyclooxygenases atherosclerosis stroke COX-2 measures kits PGF1a assays | |||
| 10008826 |
2,3- |
- |
|
2006-05-23 | 123.186533149171 | 2-3-dinor-6-keto-prostaglandin-f1-eia-kit-solid-plate | 2,3-dinor-6-keto PGF1α ELISA Kit | enzymes immunoassays Prostaglandins PGI2 prostacyclin vascular myocardial infarction cyclooxygenases stroke COX-2 inhibits measures kits PGF1a assays | |||
| 15120 |
2,3- |
- | ≥98% |
|
40.975718232044 | 2-3-dinor-6-keto-prostaglandin-f1-sodium-salt | 2,3-dinor-6-keto PGF1α (sodium salt) | PGI2 metabolites 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-6-keto-PGF1.alpha. prostaglandins | |||
| 13120 |
2,3- |
7046-40-4 | >98% |
|
25.275837937385 | 2-3-dinor-prostaglandin-e1 | 2,3-dinor PGE1 | prostaglandins 2,3-dinor-PGE1 erectile dysfunction | |||
| 13260 |
6- |
67786-53-2 | >99% |
|
67.502872928176 | 6-keto-prostaglandin-e1 | 6-keto PGE1 | 6-keto-PGE1 metabolites prostaglandins | |||
| 10007210 |
6- |
67786-53-2 | >99% |
|
2008-11-03 | 44.861528545119 | 6-keto-prostaglandin-e1-lipid-maps-ms-standard | 6-keto PGE1 | 6-keto-PGE1 metabolites prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS | ||
| 15210 |
6- |
58962-34-8 | >99% |
|
73.638353591160 | 6-keto-prostaglandin-f1 | 6-keto PGF1α | PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis | |||
| 515211 |
6- |
- |
|
353.000810313075 | 6-keto-prostaglandin-f1-eia-kit | 6-keto Prostaglandin F1α ELISA Kit | solid plates 6-keto-PGF1alpha 6-keto-PGF1.alpha. prostaglandins measures kits eias atherosclerosis enzyme immunoassays ELISAs 6-keto Prostaglandin F1.alpha. EIA Kit assays | ||||
| 10007219 |
6- |
58962-34-8 | >99% |
|
2008-12-17 | 41.464121546961 | 6-keto-prostaglandin-f1-lipid-maps-ms-standard | 6-keto PGF1α | PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis PGs MS mass spectrometry standards | ||
| 10010002 |
6- |
- | >98% |
|
✓ | 2007-07-12 | 0E-12 | 6-keto-testosterone-enanthate | esters androgens testosterone heptanoate analogs endocrinology | ||
| 10010003 |
6α- |
- | >98% |
|
✓ | 2007-07-13 | 0E-12 | 6-testosterone-enanthate | esters androgens testosterone heptanoate analogs 6alpha-testosterone enanthate 6.alpha.-Testosterone enanthate endocrinology | ||
| 10010004 |
6β- |
- | >98% |
|
✓ | 2007-07-13 | 0E-12 | 6-testosterone-enanthate | 6beta-Testosterone enanthate 6.beta.-Testosterone enanthate esters androgens testosterone heptanoate analogs endocrinology | ||
| 13360 |
8- |
21003-46-3 | >98% |
|
94.936187845304 | 8-iso-prostaglandin-e1 | Ovinonic acid; 8-iso PGE1; 8-epi PGE1 | 8-iso-PGE1 8-epi-PGE1 8-isoprostanes vasoconstriction prostaglandins | |||
| 700260 | Alanine Transaminase Activity Assay Kit | - |
|
2010-01-06 | 231.849323511357 | alanine-transaminase-activity-assay-kit | ALT Activity Assay Kit; ALAT Activity Assay Kit; Alanine Aminotransferase Activity Assay Kit; sGPT Activity Assay Kit; Serum Pyruvic Transaminase Activity Assay Kit | alanines aminotransferases homodimeric cytoplasmic pyridoxal phosphate-enzymes cells cellular nitrogen metabolism amino acids transamination a-ketoglutarates alpha-ketoglutarates α-ketoglutarates pyruvates glutamates tissues livers kidneys heart brains glucose neuronal glutamates alanine-aminotransferases reactions diseases injury diabetes cirrhosis fatty hepatitis carcinomas mononucleosis muscular dystrophy cardiovascular serums plasmas samples lysates NADH oxidations lactate dehydrogenases LDH NAD+ assays kits measures measurements | |||
| 700420 | Ascorbate Assay Kit New | - |
|
2010-09-01 | 0E-12 | ascorbate-assay-kit | L-Ascorbic Acid Assay Kit; Vitamin C Assay Kit | kits assays measures measurements ascorbates six-carbon 6-carbon six 6 carbons lactones glucose livers mammalian species humans non-human primates guinea pigs gulonolactones oxidases acids 2-keto-1-gulonolactone diets dietary scurvy electrons donors enzymes collagen hydroxylations hydroxyls groups prolines lysines molecules carnitines fatty mitochondrias ATP adenosine triphosphates generations biosynthesis norepinephrines dopamines amides groups peptides hormones tyrosines metabolisms antioxidants chronics diseases cancers cardiovascular cataracts foods industry colors tastes odors plasmas serums urines fruits juices condensations reactions dehydroascorbic DHA o-phenylenediamines OPDA fluorescent fluorescences 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy TEMPOL condensed DFQ 3-(dihydroxyethyl)-furo[34-b]-quinoxaline-1-one OPD | |||
| 10155 | BM 567 | 284464-77-3 | >98% |
|
2005-03-31 | 35.087377815554 | bm-567 | platelets thromboxanes TXA2 atherosclerosis synthases inhibits inhibition inhibitors antagonists BM567 BM-567 thrombogenic vasocontrictors TP receptors eicosanoids strokes myocardial infarctions GPCR vascular smooth muscles protein-coupled license:liege | |||
| 13281 | CAY10598 Exclusive New | 346673-06-1 | ≥98% |
|
✓ | 2010-05-07 | 28.830165745856 | cay10598 | Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection | ||
| 10012447 | CG 4305 New | - | ≥95% |
|
2010-05-12 | 0E-12 | cg-4305 | antithrombotic PGI2 epoprostenol prostacyclins platelets aggregation 89955-40-8 PGs prostaglandins I2 cartoid artery thrombosis inhibits inhibited inhibition inhibitory | |||
| 10005745 | Clofibrate | 637-07-0 | >98% |
|
2004-09-14 | 19.326398794575 | clofibrate | PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated nuclear receptors lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases homeostasis agonists selectivity atherosclerosis endocrinology fibrate | |||
| 10005056 |
Eicosapentaenoic Acid- |
145191-14-6 | ≥99% deuterated product |
|
2005-08-30 | 77.168066298342 | eicosapentaenoic-acid-d5 | EPA-d5; Timnodonic Acid-d5 | GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 inflammation analogs marine organisms coronary heart diseases thrombosis ischemic brain injury scaly dermatitis inflammatory | ||
| 10233 | FABP3 Monoclonal Antibody (Clone CC68) | - | 2009-03-20 | 21.366427255984 | fabp3-monoclonal-antibody-clone-cc68 | Cardiac FABP; Fatty acid binding protein 3; Heart fatty acid binding protein; H-FABP | antibody antisera antiserum antibodies wb western blots immunoblotting small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology blotting | ||||
| 10005368 | Fenofibrate | 49562-28-9 | >98% |
|
2004-09-15 | 34.996955801105 | fenofibrate | PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology | |||
| 13311 | Gö 6983 | 133053-19-7 | ≥98% |
|
2009-10-07 | 28.101503551697 | g-6983 | proteins kinases C PKC α β γ δ ζ µ hearts cardioprotection ischemia reperfusion injuries contractile dyfunction alpha beta gamma delta zeta micro Goe Goe6983 Go-6983 Go 6983 | |||
| 13705 |
HCN1 Cyclic Nucleotide- |
- | 2009-12-01 | 0E-12 | hcn1-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s70-28 | antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-1 HCN 1 | |||||
| 13707 |
HCN2 Cyclic Nucleotide- |
- | 2009-12-01 | 0E-12 | hcn2-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s71-37 | antibodies western blots blotting immunoblotting WB immunohistochemistry IHC ions channels HCN-2 HCN 2 ICC immunocytochemistry immunoprecipitation IP | |||||
| 13708 |
HCN3 Cyclic Neuclotide- |
- | 2009-12-01 | 0E-12 | hcn3-cyclic-neuclotide-gated-channel-monoclonal-antibody-clone-s141-28 | antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-3 HCN 3 | |||||
| 13709 |
HCN4 Cyclic Nucleotide- |
- | 2009-12-02 | 0E-12 | hcn4-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s114-10 | antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-4 HCN 4 hyperpolarization-activated cation gene family hyperpolarization activated activity activates | |||||
| 13624 | Icariin | 489-32-7 | ≥97% |
|
2010-02-11 | 62.642659719415 | icariin | PDE5 inhibitors flavonoids differentiation cancers proliferation flavonols E brevicornum horny goat weed BMP2 ED erectile dysfunction | |||
| 13711 |
KCNQ1 Potassium Channel Monoclonal Antibody (Clone S37A- |
- | 2009-12-02 | 0E-12 | kcnq1-potassium-channel-monoclonal-antibody-clone-s37a-10 | antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-1 IKs inner ears cardiac muscles channels Kv7.1 hyperpolarization-activated cation hyperpolarization activated activity activate | |||||
| 13714 |
Kir2.1 Potassium Channel Monoclonal Antibody (Clone S21- |
- | 2009-12-02 | 0E-12 | kir2-1-potassium-channel-monoclonal-antibody-clone-s21-32 | channels antibodies western blots blotting immunoblotting WB immunohistochemistry IHC KCNJ2 genes Andersen-Tawil syndromes Andersen Tawil AT defects | |||||
| 13715 |
Kir2.2 Potassium Channel Monoclonal Antibody (Clone S24- |
- | 2009-12-02 | 0E-12 | kir2-2-potassium-channel-monoclonal-antibody-clone-s24-1 | channels ions antibodies western blots blotting immunoblotting WB immunohistochemistry IHC syndromes Smith-Magenis Smith Magenis chromosomes 17 seventeen tissues genes | |||||
| 13716 |
Kir2.3 Potassium Channel Monoclonal Antibody (Clone S25- |
- | 2009-12-04 | 0E-12 | kir2-3-potassium-channel-monoclonal-antibody-clone-s25-35 | antibodies channels ions western blots blotting immunoblotting WB IHC immunohistochemistry genes proteins potassiums | |||||
| 13810 | Limaprost | 74397-12-9 | >98% |
|
45.744226519337 | limaprost | 17α,20-dimethyl-Δ2-Prostaglandin E1; 17α,20-dimethyl-Δ2-PGE1 | PGE1 analogs inhibitors platelets aggregation prostaglandins | |||
| 390150 |
Linoleic Acid- |
79050-23-0 | ≥99% deuterated product |
|
✓ | 18.640441988949 | linoleic-acid-d4 | standards deuterated deuterium GC/MS internal isotopes GC-MS LC/MS LC-MS mass spectrometry fatty acids | |||
| 16833 | Lisinopril | 76547-98-3 | ≥98% |
|
2009-03-09 | 2.077348066299 | lisinopril | MK 522; MK 521 | inhibitors inhibits inhibition angiotensin I II ACE endothelin 1 nitric oxide renin hypertension diabetes | ||
| 585001 | Myeloperoxidase (human) EIA Kit | - |
|
2009-05-05 | 52.057329650091 | myeloperoxidase-human-eia-kit | MPO (human) EIA Kit | myeloperoxidases controls standards EIAs ELISAs enzymes immunometrics assays leukocytes oxidants atherosclerotic atherosclerosis plaques prothrombogenicity cytotoxic cytotoxins nitric oxides vasocontrictions vasocontrictors plasma blood ACS acute coronary syndromes cardiac myocardial infarction revascularization death assays | |||
| 700170 | Myeloperoxidase Inhibitor Screening Assay Kit | - |
|
2009-04-14 | 24.480939226519 | myeloperoxidase-inhibitor-screening-assay-kit | MPO Inhibitor Screening Assay Kit | heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 2-[6-(4-aminophenoxy)-3-oxo-3H-xanthen-9-yl]-benzoic acid APF -OCl assays | |||
| 700160 | Myeloperoxidase Peroxidation Assay Kit | - |
|
2009-04-14 | 33.896593001842 | myeloperoxidase-peroxidation-assay-kit | MPO Peroxidation Assay Kit | heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin | |||
| 10010653 |
Nisoldipine- |
- | ≥99% deuterated product |
|
2009-04-15 | 0E-12 | nisoldipine-d3 | 63675-72-9 86189-67-5 calcium channel dihydropyridine cardiac failure angina deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry | |||
| 512031 | Prostaglandin D2 EIA Kit New | - |
|
2010-07-19 | 0E-12 | prostaglandin-d2-eia-kit | PGD2 ELISA Kit | PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions | |||
| 512041 | Prostaglandin D2 Express EIA Kit New | - |
|
2010-07-19 | 0E-12 | prostaglandin-d2-express-eia-kit | PGD2 Express ELISA Kit | PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions | |||
| 12990 | Prostaglandin D3 | 71902-47-1 | >98% |
|
97.405607734806 | prostaglandin-d3 | PGD3 | PGD3 omega-3 w-3 .omega.-3 metabolites EPA eicoaspentaenoic acid prostaglandins | |||
| 13010 | Prostaglandin E1 | 745-65-3 | >98% |
|
69.748572259377 | prostaglandin-e1 | Alprostadil; PGE1 | PGE1 vasodilation atherosclerosis erectile dysfunction prostaglandins pharma:1 | |||
| 13010.1 | Prostaglandin E1 Analytical Reference Standard | 745-65-3 | >99% |
|
27.062348066298 | prostaglandin-e1-analytical-reference-standard | Alprostadil; PGE1 | PGE1 vasodilation USP erectile dysfunction prostaglandins | |||
| 13082 | Resorcinolnaphthalein | 41307-63-5 | ≥98% |
|
2009-02-24 | 66.719907918969 | resorcinolnaphthalein | NSC 354317 | angiotensin converting enzyme 2 ACE2 hypertension blood pressure activators fibrosis | ||
| 10012555 | Sodium Hydrogen Sulfide (hydrate) | 207683-19-0 | ≥65% |
|
2009-09-03 | 7.244880294659 | sodium-hydrogen-sulfide-hydrate | Sodium Hydrosulfide; NSC 158264; NaHS | hydrogen sulfide H2S donor inflammation oxidative stress cardiocascular neurological neurons pulmonary leukocytes neutrophils pain 1310-76-5 64568-18-9 111883-06-8 16721-80-5 | ||
| 10162 | Treprostinil | 81846-19-7 | >98% |
|
2005-08-30 | 107.833449969306 | treprostinil | primary pulmonary hypertension PPH arterial vascular resistance stable analogs prostacyclins increase plasma half-life vasodilatory inhibits inflammatory cytokines inhibition inhibitors GM-CF human alveolar macrophages NF-KB NF-.kappa. translocations nucleus NF-kappaB nfkb nf-kb NF-.kappa.B atherosclerosis | |||
| 18113 |
YM- |
182959-33-7 | ≥98% |
|
✓ | 2009-08-11 | 32.830607734807 | ym-53601 | squalene synthases inhibitors cholesterol triglycerides HMG-CoA reductase fibrates hyperlipidemia hypercholesterolemia lipid-lowering activities inhibitor inhibited | ||
| 90210 |
α- |
463-40-1 | >98% |
|
8.872304656669 | -linolenic-acid | ALA | fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 essential leafy green vegetables alpha-linolenic .alpha.-linolenic | |||
| 10010001 |
Δ- |
- | >98% |
|
2007-07-12 | 0E-12 | -6-testosterone-enanthate | DELTA-6-testosterone enanthate .DELTA.-6-testosterone enanthate .DELTA.6-testosterone enanthate esters androgens testosterone heptanoate analogs endocrinology |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2010 Cayman Chemical Company
Quick Search